Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,454 | -23,789 | -19,404 | -24,790 | -34,345 |
| Depreciation Amortization | 65 | 11 | 6 | 5 | 333 |
| Other Working Capital | 1,869 | -2,513 | -112 | 235 | 1,969 |
| Other Operating Activity | 7,822 | 11,317 | 1,713 | 3,171 | 6,974 |
| Operating Cash Flow | $-18,697 | $-14,974 | $-17,796 | $-21,380 | $-25,069 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -58 | -150 | -7 | -3 | -12 |
| Net Acquisitions | N/A | 509 | N/A | N/A | N/A |
| Purchase Of Investment | -69,781 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 4,984 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | -82 | 0 | 0 | 0 |
| Investing Cash Flow | $-64,856 | $277 | $-7 | $-3 | $-12 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -1,219 |
| Common Stock Issued | 81,569 | 16,726 | 24,375 | 4,897 | 49,989 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -1,284 |
| Financing Cash Flow | $81,569 | $16,726 | $24,375 | $4,897 | $47,485 |
| Beginning Cash Position | 29,091 | 27,061 | 20,489 | 36,975 | 14,571 |
| End Cash Position | 27,108 | 29,091 | 27,061 | 20,489 | 36,975 |
| Net Cash Flow | $-1,984 | $2,030 | $6,572 | $-16,486 | $22,404 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,697 | -14,974 | -17,796 | -21,380 | -25,069 |
| Capital Expenditure | -58 | -150 | -7 | -3 | -12 |
| Free Cash Flow | -18,756 | -15,124 | -17,803 | -21,383 | -25,081 |